Document:

Exhibit 10.5

 

AMENDED AND RESTATED SECURITY AGREEMENT

 

THIS SECURITY AGREEMENT (this
“Agreement”), dated as of March 31, 2022, is made by CELLVERA ASIA LIMITED, a company formed under the laws of Hong
Kong f/k/a AIPHARMA ASIA LIMITED (“Grantor”) in favor of ADITXT, INC., a Delaware corporation (“Secured Party”),
with reference to the following facts:

 

RECITALS

 

A. Secured
Party extended certain financial accommodations to CELLVERA GLOBAL HOLDINGS LLC, a Delaware limited liability company f/k/a AIPHARMA GLOBAL
HOLDINGS LLC, CELLVERA HOLDINGS LTD, a company formed under the laws of the British Virgin Islands f/k/a AIPHARMA HOLDINGS LIMITED and
Grantor (individually and collectively, “Company”), pursuant to the Secured Credit Agreement dated as of August 27,
2021, as amended by the First Amendment to Secured Credit Agreement, dated as of October 18, 2021, the Second Amendment to Secured Credit
Agreement, dated as of October 27, 2021, the Third Amendment to Secured Credit Agreement, dated as of December 1, 2021, the Fourth Amendment
to Secured Credit Agreement dated as of December 17, 2021, the Fifth Amendment to Secured Credit Agreement, dated as of December 22, 2021,
the Sixth Amendment to Secured Credit Agreement, dated as of December 28, 2021, the Forbearance Agreement and Seventh Amendment to Secured
Credit Agreement, dated as of February 13, 2022 and the Forbearance Agreement and Eighth Amendment of even date herewith (as may be further
amended or otherwise modified from time to time, the “Credit Agreement”)

 

B. Grantor
has directly benefited from the financial accommodations provided to Company and, in order to induce Secured Party to provide such accommodations,
Grantor has agreed to grant to Secured Party a continuing security interest in the Collateral (defined below) in order to secure the prompt
and complete payment, observance and performance of the Obligations (defined below).

 

AGREEMENT

 

NOW, THEREFORE, for good and
valuable consideration, the receipt and adequacy of which are hereby acknowledged, and incorporating the recitals set forth above, Grantor
hereby jointly and severally represents, warrants, covenants, agrees, assigns and grants as follows:

 

		1.	Definitions. Terms defined in the Delaware Uniform Commercial Code (the “UCC”)
and not otherwise defined in this Agreement shall have the meanings defined for those terms in the UCC. As used in this Agreement, the
following terms shall have the meanings respectively set forth after each:

 

“Collateral” means and
includes all of Grantor’s now owned or hereafter acquired assets, whether tangible or intangible, including without limitation all
of such Grantor’s right, title and interest in and to each of the following, wherever located and whether now existing or hereafter
arising or acquired: (a) all accounts, (b) all inventory, (c) all equipment and fixtures, (d) all contract rights, (e) all general intangibles,
including without limitation payment intangibles and software, (f) all intellectual property, (g) all securities accounts, deposit accounts,
cash, money, drafts, certificates of deposit, and general and special deposits, (h) all investment property and financial assets (other
than margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System), (i) all instruments, (j)
all chattel paper, including without limitation, electronic chattel paper, (k) all goods and all accessions thereto, (l) all healthcare-insurance
receivables, (m) all leases, (n) all reporting obligations, (o) all documents, (p) all letter of credit rights, (q) all insurance and
certificates of insurance pertaining to any and all items of Collateral, (r) all books and records, (s) all files, correspondence, computer
programs, tapes, disks and related data processing software and other media which contain information identifying or pertaining to any
of the Collateral or any Account Debtor or showing the amounts thereof or payments thereon or otherwise necessary or helpful in the realization
thereon or the collection thereof, (t) all commercial tort claims, including, without limitation, those described on Schedule 1.1 hereto,
if any, and (u) any and all products and cash and non-cash proceeds of the foregoing (including, but not limited to, any claims to any
items referred to in this definition and any claims against third parties for loss of, damage to or destruction of any or all of the Collateral
or for proceeds payable under or unearned premiums with respect to policies of insurance) in whatever form; provided, however, that “Collateral”
shall not include the Excluded Property.

 

     

     

    

 

“Excluded Property”
means (a) any lease, license or contract to which a Borrower is a party, or any license, consent, permit, variance, certification, authorization
or approval of any Governmental Authority (or any person acting on behalf of a Governmental Authority) of which a Borrower is the owner
or beneficiary, or any of its rights or interests thereunder, if and for so long as the grant of a security interest therein shall constitute
or result in (i) the abandonment, invalidation or unenforceability of the right, title or interest of such Borrower therein or (ii) a
breach or termination pursuant to the terms of, or a default under, such lease, license or contract or such license, consent, permit,
variance, certification, authorization or approval (other than, in the case of clauses (i) and (ii), to the extent that any such term
would be rendered ineffective pursuant to Section 9.406, 9.407, 9.408 or 9.409 of the UCC or any other Applicable Law or principles
of equity); (b) any equipment owned by a Borrower on the Closing Date or hereafter acquired that is subject to a purchase money lien or
a Lien securing a Capitalized Lease Obligation permitted to be incurred hereunder if the contract or other agreement (or the documentation
providing for such permitted purchase money debt or Capitalized Lease) in which such Lien is granted validly prohibits the creation of
any other Lien on such equipment; (c) any intent-to-use trademark application prior to the filing and acceptance of evidence of the
use of such trademark in interstate commerce to the extent, if any, that and solely during the period, if any, in which, the grant of
a security interest therein would impair the validity or enforceability of such intent-to-use trademark application under Applicable Law;
provided that if any Excluded Property would otherwise constitute Collateral, then, immediately upon such property ceasing to constitute
Excluded Property for any reason, such property shall be deemed at all times from and after the date thereof to constitute Collateral.
For the avoidance of doubt, if any party to a contract that contains an Anti-Assignment Clause that is enforceable notwithstanding the
application of Section 9.406, 9.407, 9.408 or 9.409 of the UCC, subsequently consents to Secured Party’s security interest
in such contract, such contract shall not be deemed to be Excluded Property and Secured Party’s security interest in such contract
shall be deemed to have attached effective on the Closing Date.

 

“Event of Default” shall
occur upon the occurrence of an “Event of Default” under the Credit Agreement.

 

“Laws”
means, collectively, all international, foreign, federal, state and local statutes, treaties, rules, regulations, ordinances, codes and
administrative or judicial precedents.

 

“Loan Documents”
has the meaning given to it in the Credit Agreement.

 

“Obligations”
has the meaning given to it in the Credit Agreement.

 

    - 2 -

     

    

 

“Person” means any
individual, corporation, joint venture, limited liability company, partnership, trust, unincorporated organization or governmental entity
or agency.

 

		2.	Security Agreement. For valuable consideration, Grantor hereby assigns and pledges to Secured Party,
and grants to Secured Party a security interest in, all presently existing and hereafter acquired Collateral, as security for the timely
payment and performance of the Obligations. Grantor authorizes Secured Party to file on behalf of Grantor any financing statement, amendment
thereto or continuation thereof.

 

		3.	Rights Upon Event of Default. Upon the occurrence of an Event of Default, Secured Party may from time to time, without notice
of election and without demand, enter upon any premises where Collateral is located; and exercise any or all rights and remedies available
under the Loan Documents, at law and/or in equity including, without limitation, the rights and remedies of a secured party under the
UCC. The rights and remedies of Secured Party under this Agreement and the other Loan Documents shall be cumulative. Secured Party shall
have all other rights and remedies not inconsistent herewith as provided by Law, or in equity. No exercise by Secured Party of one right
or remedy shall be deemed an election, and no waiver by Secured Party of any default on Grantors’ part shall be deemed a continuing waiver.
No delay by Secured Party shall constitute a waiver, election or acquiescence.

 

		4.	Waivers and Consents. Grantor consents and agrees that Secured Party may, at any time and from time to time, without notice
or demand, and without affecting the enforceability of this Agreement:

 

		a)	supplement, modify, amend, extend, renew, accelerate, or otherwise change the time for payment or the terms of the Obligations or
any part thereof;

 

		b)	supplement, modify, amend or waive, or enter into or give any agreement, approval or consent with respect to, the Obligations or any
part thereof or the Loan Documents or any additional guaranties, or any condition, covenant, default, remedy, right, representation or
term thereof or thereunder;

 

		c)	accept new or additional instruments, documents or agreements in exchange for or relative to any of the Loan Documents or the Obligations
or any part thereof;

 

		d)	accept partial payments on the Obligations;

 

		e)	release Company, any guarantor or any other Person from any liability with respect to the Obligations or any part thereof;

 

		f)	settle, release on terms satisfactory to Secured Party or by operation of applicable laws or otherwise liquidate or enforce any Obligations
or guaranty therefor in any manner; and

 

		g)	consent to the merger, change or any other restructuring or termination of the corporate existence of Company, and correspondingly
restructure the Obligations, and any such merger, change, restructuring or termination shall not affect the liability of Grantor.

 

    - 3 -

     

    

 

Secured Party may enforce this Agreement
independently of any other remedy Secured Party at any time may have or hold in connection with the Obligations, and it shall not be necessary
for Secured Party to marshal assets in favor of Grantor or any other Person or to proceed upon or against and/or exhaust any remedy before
proceeding to enforce this Agreement. Grantor expressly waives, any right to require Secured Party to marshal assets in favor of Grantor
or any other Person or to proceed against any other Person, and agrees that Secured Party may proceed against any Person in such order
as it shall determine in its sole and absolute discretion. Secured Party may file a separate action or actions against Company and Grantor,
whether action is brought or prosecuted with respect to any other Person, or whether any other Person is joined in any such action or
actions. Grantor agrees that Secured Party and Company and any other Person may deal with each other in connection with the Obligations
or otherwise, or alter any contracts or agreements now or hereafter existing between any of them, in any manner whatsoever, all without
in any way altering or affecting this Agreement. Secured Party’s rights hereunder shall be reinstated and revived, and the enforceability
of this Agreement shall continue, with respect to any amount at any time paid on account of the Obligations which thereafter shall be
required to be restored or returned by Secured Party upon the bankruptcy, insolvency or reorganization of Company or any other Person
or otherwise, all as though such amount had not been paid. The enforceability of this Agreement at all times shall remain effective even
though the Obligations, including any part thereof may be or hereafter may become invalid or otherwise unenforceable as against Company
or any other Person and whether or not Company or any other Person shall have any personal liability with respect thereto. Grantor expressly
waives any and all defenses now or hereafter arising or asserted by reason of (i) any disability or other defense of Company or any
other Person with respect to the Obligations, (ii) the cessation for any cause whatsoever of the liability of Company or any other Person
(other than by reason of the full payment and performance of all Obligations), (iii) any failure of Secured Party to marshal assets
in favor of Grantor or any other Person, (iv)  any act or omission of Secured Party or others that directly or indirectly results
in or aids the discharge or release of Company or any other Person or the Obligations, (v) any law which provides that the obligation
of a surety or guarantor must neither be larger in amount nor in other respects more burdensome than that of the principal or which reduces
a surety’s or guarantor’s obligation in proportion to the principal obligation, (vi) any failure of Secured Party to file or enforce
a claim in any bankruptcy or other proceeding with respect to any Person, or (vii) any bankruptcy, insolvency, reorganization, arrangement,
readjustment of debt, liquidation or dissolution proceeding commenced by or against any Person, including any discharge of, or bar or
stay against collecting, all or any of the Obligations (or any interest thereon) in or as a result of any such proceeding. Except as provided
herein, Grantor expressly waives all setoffs and counterclaims and all presentments, demands for payment or performance, notices of nonpayment
or nonperformance, protests, notices of protest, notices of dishonor and all other notices or demands of any kind or nature whatsoever
with respect to the Obligations, and all notices of acceptance of this Agreement or of the existence, creation or incurring of new or
additional Obligations, except for those arising from or relating to the gross negligence or willful misconduct of Secured Party.

 

		5.	Condition of Company. Grantor represents and warrants to Secured Party that it has established adequate means of obtaining
from the Company, on a continuing basis, financial and other information pertaining to the business, operations and condition (financial
and otherwise) of the Company and its assets, and Grantor now is and hereafter will be completely familiar with the business, operations
and condition (financial and otherwise) of the Company and its assets. Grantor hereby expressly waives and relinquishes any duty on the
part of Secured Party to disclose to Grantor any matter, fact or thing related to the businesses, operations or condition (financial or
otherwise) of the Company and its assets, whether now known or hereafter known by Secured Party during the life of this Agreement. With
respect to any of the Obligations, Secured Party need not inquire into the powers of Company, or the officers or employees acting or purporting
to act on its behalf, and all Obligations made or created in good faith reliance upon the professed exercise of such powers shall be secured
hereby.

 

    - 4 -

     

    

 

		6.	Waiver of Rights of Subrogation. Until all of the Obligations have been paid and performed in full, notwithstanding anything
to the contrary elsewhere contained herein or in any other Loan Document to which Grantor is a party, Grantor hereby waives with respect
to the Company, its successors and assigns (including any surety) and any other Person any and all rights at law or in equity, to subrogation,
to reimbursement, to exoneration, to indemnity, to contribution, to setoff or to any other rights that could accrue to a surety against
a principal, to a guarantor against a maker or obligor, to an accommodation party against the party accommodated, or to a holder or transferee
against a maker and which Grantor may have or hereafter acquire against Company in connection with or as a result of Grantor’s execution,
delivery and/or performance of this Agreement or any other Loan Document to which Grantor is a party.

 

		7.	Waiver of Discharge. Without limiting the generality of the foregoing, Grantor hereby waives discharge by waiving all defenses
based on suretyship or impairment.

 

		8.	Understandings with Respect to Waivers and Consents. Grantor warrants and agrees that each of the waivers and consents set
forth herein is made after consultation with legal counsel and with full knowledge of its significance and consequences, with the understanding
that events giving rise to any defense or right waived may diminish, destroy or otherwise adversely affect rights which Grantor otherwise
may have against Company, Secured Party or others and that, under the circumstances, the waivers and consents herein given are reasonable
and not contrary to public policy or law. If any of the waivers or consents herein are determined to be contrary to any applicable law
or public policy, such waivers and consents shall be effective to the maximum extent permitted by law.

 

		9.	Amended and Restated Agreement. This Agreement amends, restates and supersedes the Security Agreement, dated as of August 27,
2021, by Grantor in favor of Secured Party.

 

		10.	Miscellaneous Provisions. Article VIII of the Credit Agreement is hereby incorporated herein by this reference mutatis mutandis.
Without limiting the foregoing, Grantor agrees that this Agreement shall be interpreted in accordance with Delaware law and that any dispute
will be determined by and arbitral tribunal in accordance with Section 8.09(c) of the Credit Agreement on the “side” of the
Borrower.

 

[Signature page follows]

 

    - 5 -

     

    

 

IN WITNESS WHEREOF, Grantor has executed this Agreement
by its duly authorized officer as of the date first written above.

 

	 	“Grantor”
	 	 
	 	CELLVERA ASIA LIMITED, a company formed under the laws of Hong Kong f/k/a AIPHARMA ASIA LIMITED 
	 	 	 
	 	By:	/s/ Alessandro Gadotti
	 	 	 
	 	Name:	Alessandro Gadotti
	 	Title:	Legal Representative
	 	 	 
	 	Acknowledged and accepted:
	 	 
	 	“Secured Party”
	 	 
	 	ADITXT, INC., a Delaware corporation
	 	 	 
	 	By:	/s/ Amro Albanna
	 	Name:	Amro Albanna
	 	Title:	CEO

 

[Signature Page to Security Agreement –
DE Law]

 

 

- 6 -Exhibit 10.6

 

REVENUE SHARING AGREEMENT

This Revenue Sharing Agreement ("Agreement")
is made as of March 31, 2022, by and among ADITXT, INC., a Delaware corporation (the “Lender” or “Aditxt”),
CELLVERA GLOBAL HOLDINGS LLC, a Delaware limited liability company f/k/a AIPHARMA GLOBAL HOLDINGS LLC (“DE Topco”),
CELLVERA HOLDINGS LTD, a company formed under the laws of the British Virgin Islands f/k/a AIPHARMA HOLDINGS LIMITED (“BVI Holdco”),
Cellvera Asia Limited, a company formed under the laws of Hong Kong f/k/a AIPHARMA ASIA
LIMITED (“HK Opco” and together with DE Topco and BVI Holdco, individually and collectively, the “Borrower”),
CELLVERA LIMITED, a company formed under the laws of the British Virgin Islands f/k/a AIPHARMA LIMITED (“Guarantor”
and together with Borrower, each a “Loan Party” and collectively “Loan Parties” or “Revenue
Sharing Entities”).

 

Recitals

 

A. As contemplated
pursuant to the Exchange Agreement, Aditxt made loans (the “Loans”) to Borrower pursuant to the Secured Credit Agreement
dated as of August 27, 2021, as amended by the First Amendment to Secured Credit Agreement, dated as of October 18, 2021, the Second Amendment
to Secured Credit Agreement, dated as of October 27, 2021, the Third Amendment to Secured Credit Agreement, dated as of December 1, 2021,
the Fourth Amendment to Secured Credit Agreement dated as of December 17, 2021, the Fifth Amendment to Secured Credit Agreement, dated
as of December 22, 2021, and the Sixth Amendment to Secured Credit Agreement, dated as of December 28, 2021, the Forbearance Agreement
and Seventh Amendment to Secured Credit Agreement, dated as of February 13, 2022, and the Forbearance Agreement and Eighth Amendment to
Secured Credit Agreement dated of even date herewith (as may be further amended or otherwise modified from time to time, the "Credit
Agreement"). The Loans are secured by the collateral described in certain security documents entered into from time to time,
as more particularly described in the Credit Agreement (the “Security Documents”).

 

B. The
Maturity Date of the Loan (being January 31, 2021) was determined by reference to the expected date of initial closing under the Share
Exchange Agreement. As a result of failing to close the Initial Closing under the Share Exchange Agreement, Borrower failed to repay all
of the Loans (including all principal, interest, fees and expenses thereon) on the Maturity Date (the “Existing Event”)
as required by Section 2.03 of the Credit Agreement. As a result, from and after February 1, 2022, interest has accrued and continues
to accrue at the Default Rate (i.e. 13.00% per annum) until all Loans and other Obligations are repaid in full. As a result of the above,
Lender agreed to forbear from enforcing its other rights and remedies in response to the occurrence of the Existing Event on the terms
and conditions set forth in the Forbearance Agreement and Seventh Amendment to Secured Credit Agreement, dated as of February 14, 2022
(the “February Forbearance Agreement”).

 

C. The
Forbearance Period terminated as a result of the occurrence of certain Forbearance Defaults resulting from Borrower’s failure to
pay the February 28, 2022 and March 5, 2022 payments as required pursuant to the February Forbearance Agreement. As a result of the occurrence
of the Existing Event and the termination of the Forbearance Period pursuant to the February Forbearance Agreement, Aditxt is permitted
to exercise all of its rights and remedies under the Credit Agreement and the Security Documents.

 

D Loan
Parties have requested that Aditxt forbear from exercising its default rights and remedies in respect of the Existing Event in accordance
with the terms of the Forbearance Agreement and Eighth Amendment to Secured Credit Agreement dated of even date herewith (the “March
Forbearance Agreement”).

 

E. As a
condition to entering into the March Forbearance Agreement, Revenue Sharing Entities are required to enter into this Agreement. Each of
the Revenue Sharing Entities will receive substantial benefits under the March Forbearance Agreement.

 

     

     

    

 

AGREEMENT

 

NOW THEREFORE, in consideration of the foregoing
and for other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1. Defined Terms. Initially
capitalized terms used but not defined herein shall have the meanings given to them in the March Forbearance Agreement. This Agreement
is not a “Loan Document” but is given as consideration for Aditxt’s agreement to enter into the March Forbearance
Agreement. For purposes of this Agreement, the following initially capitalized terms will have the following meanings:

 

“Affiliate” means any asset, business,
business line, company, entity, product, product line, service, or service line that is or becomes controlled by or under common control
with a Revenue Sharing Entity, whether such control is based on the ability to direct management, assignment of title, license rights,
contract, conveyance, merger, operation of law, ownership of at least thirty percent (30%) of the voting power, or otherwise.

 

“Net Sales” means the actual gross amounts
invoiced and collected by any Loan Party on all of their sales of products or services to third parties less only the following
documented costs actually and reasonably paid or delivered to unaffiliated third parties and not refunded, credited back to, exchanged
for other products or services, or offset by any Loan Party (which documentation shall be delivered to Lender upon request).

 

(a) cost of raw materials
for products and services sold (including cost of freight carriers for exporting products outside of the country of origin), but excluding
general administrative costs );

 

(b) sales and excise
taxes or other applicable taxes, value added taxes, and duties which fall due and are paid by the purchaser as a direct consequence of
such sales and any other governmental charges imposed upon the importation, use or sale of the product or service, but only to the extent
that such taxes and duties are;

 

(i) actually included
and itemized in the gross amounts invoiced to and specifically paid by the purchaser over and above the usual selling price of the product,
and

 

(ii) customarily
included and itemized in the gross amounts invoiced to and specifically paid by the purchaser over and above the usual selling price of
all comparable products in the relevant market.

 

(c) trade, quantity
and cash discounts that are of amounts customary in the pharmaceutical industry for companies of a similar size, revenue, geography and
product line and that are actually allowed or accrued on the product or service;

 

(d) allowances or credits to customers on account of off-invoice promotional
discounts, price and shelf adjustments, volume reimbursements, failure to supply, rejection, withdrawal, recall, or return of the product
or on account of retroactive price reductions affecting the product or service, to the extent that such allowances or credits are of amounts
customary in the pharmaceutical industry for companies of a similar size, revenue, geography, product line and service line and are actually
allowed or accrued on the product or service;

 

    2

     

    

 

(e) rebates, discounts and charge backs specifically related to the
product or service on an actual credited, paid or accrued basis that are of amounts customary in the pharmaceutical industry for companies
of a similar size, revenue, geography and product line, including, but not limited to, those granted to government agencies;

 

		(f)	service allowances (including, but not limited to, wholesalers' fees for services) and independent broker or agents' commissions,
if any, allowed or paid and that are of amounts customary in the pharmaceutical industry for companies of a similar size, revenue, geography,
product line and service line;

 

		(g)	any bona fide and regular credit note issued by licensee to the customers (provided that upon payment or hypothecation of any amount
of principal outstanding of such credit note, and/or interest thereon, such amount so received from such payment or hypothecation shall
be included in Net Sales);

 

		(h)	royalties required to be paid to FUJIFILM Toyama Chemical Co., Ltd. or any other owner or enforcer of intellectual property rights
under any license agreement in respect of the product;

 

		(i)	fees, commissions and costs required to be paid to distributors or sales agents in relation to the sale of the product that are of
amounts customary in the pharmaceutical industry for companies of a similar size, revenue, geography and product line of the Loan Party;
and

 

		(j)	fees, commissions and costs required to be paid in relation to the factoring of any invoices in respect of the product that are of
amounts customary in the pharmaceutical industry for companies of a similar size, revenue, geography and product line of the Loan Party.

 

Net Sales with respect to sales of the product that are not
made on an arm's length basis or that are made for consideration other than cash shall be calculated based on the average per-unit Net
Sales of the product without regard to such non-arm's length or non-cash sales and without regard to product given pro bono or for charitable
or clinical use. If the product is bundled with other products, any discounts or other adjustments with respect to the product shall be
allocated proportionally to the product at no greater than the non-bundled discount rate for the product.

 

Product given to third parties pro bono or for charitable
use or given to third parties for the execution of clinical trials are excluded from the Net Sales calculation.

 

2. Incorporation of Recitals.
Each of the above recitals is incorporated herein as true and correct and is relied upon by Aditxt in agreeing to the terms of this Agreement.

 

3. Revenue Sharing.
In consideration of the forbearance provided for in the Forbearance Agreement and Eighth Amendment to the Secured Credit Agreement, each
Loan Party, on behalf of itself and its respective Affiliates, severally and jointly, hereby irrevocably and forever agrees to pay US$30,000,000
in accordance with Section 4 below (the “Revenue Share”) to Aditxt.

 

4. Payments. Each Revenue
Sharing Entity, on behalf of itself and its Affiliates, covenants and agrees, jointly and severally, to deposit the Revenue Share within
ten (10) days following receipt thereof to the bank account designated by Aditxt in the Credit Agreement, as follows:

 

		a.	ten percent (10%) of all Net Sales until $18,000,000 has been received by Lender pursuant this Section 5 (the “First Level
Threshold”);

 

		b.	upon payment of the First Level Threshold and until $23,000,000 has been received by Lender pursuant this Section 3, seven percent
(7%) of all Net Sales (“Second Level Threshold”); and

 

		c.	upon payment of the Second Level Threshold and until $30,000,000 has been received by Lender pursuant this Section 3, three percent
(3%) of all Net Sales.

 

    3

     

    

 

The Parties agree that upon payment of the total Revenue Share, the
obligations of the Revenue Share Entities to pay any Revenue Share to Lender shall cease.

 

5. Application to Outstanding
Obligations. Subject to the terms and conditions of the Credit Agreement, during the Forbearance Period, Aditxt agrees to apply one
hundred percent (100%) of any Revenue Share payments actually received by Aditxt from the Revenue Sharing Entities and their respective
Affiliates pursuant to this Agreement, to the Obligations until the Obligations are paid in full or otherwise extinguished. During the
Forbearance Period, all such payments shall be applied in accordance with Section 7(a) of the March Forbearance Agreement.

 

6. Cooperation. Each
Revenue Sharing Entity will, and will cause its Affiliates to, cooperate with Aditxt and Aditxt’s auditors in connection with auditing,
reviewing, monitoring and administration of the Revenue Sharing payments. Without limiting the foregoing, each Revenue Sharing Entity,
on behalf of itself and its Affiliates, authorizes Aditxt and Aditxt’s auditors to verify accounts receivable, bank statements,
and other books and records of such Revenue Sharing Entity and its Affiliates with their respective accountants, auditors, banks, customers,
creditors, debtors’, partners, and personnel.

 

7. No Offset Rights.
Each Revenue Sharing Entity, on behalf of itself and its Affiliates, covenants and agrees that none of them shall have or exercise any
claims, offsets or defenses with respect to any Revenue Share payments.

 

8. Remedies. No failure
or delay on the part of Aditxt in exercising any power, right or remedy under this Agreement shall operate as a waiver thereof, and no
single or partial exercise of any such power, right or remedy shall preclude any further exercise thereof or the exercise of any other
power, right or remedy.

 

9. Revenue Sharing Entities'
Representations and Warranties. Each Revenue Sharing Entity represents, warrants, and covenants, severally and jointly, on behalf
of itself and its Affiliates, to Aditxt as follows:

 

		a)	Each Person executing and delivering this Agreement to Aditxt on behalf of a trust, company, corporation or limited liability company,
which is a Revenue Sharing Entity, has all necessary authority to enter into this Agreement on behalf of such Revenue Sharing Entity and
its Affiliates.

 

		b)	All representations and warranties made and given by each Loan Party in the Loan Documents are true, complete, accurate and correct
in all material respects.

 

    4

     

    

 

		c)	This Agreement constitutes a valid and binding obligation of the Revenue Sharing Entities and their respective Affiliates that is
enforceable in accordance with its terms.

 

10. Miscellaneous Provisions.

 

		a)	Transfers. In connection with (a) any assignment, license, merger, or transfer, whether by operation of law or otherwise (“Transfer”)
of this Agreement, (b) the sale of any Revenue Sharing Entity, its Affiliates, (c) the sale all or substantially all of the assets of
any Revenue Sharing Entity, its Affiliates, or any revenue generating asset, business line, product line, or service line, or any copyrights,
patent rights, marks, or other rights, titles or interests in or to proprietary or intellectual property, then each recipient thereof
shall expressly agree in writing to be bound by all of Aditxt’s rights, titles, and interests set forth herein and to assume all
of the Revenue Sharing Entities’ representations, warranties, covenants and obligations hereunder, and to expressly name Aditxt
as a third party beneficiary therein. Any Transfer in violation of this Section 11 shall be null and void ab initio.

 

		b)	Notices. All notices shall be given in the manner set forth in the Credit Agreement.

 

		c)	Severability. If any provision of this Agreement is deemed to be unenforceable, then Aditxt shall have the sole and absolute
right to amend or delete such provision to Aditxt’s benefit.

 

		d)	Effect of Agreement. Each Revenue Sharing Entity acknowledges that it has consulted with counsel and such other experts and
advisors as it deems necessary in connection with the negotiation, execution and delivery of this Agreement, or has had an opportunity
to so consult and has knowingly chosen not to do so. This Agreement shall be binding upon and inure to the benefit of and be enforceable
by the parties hereto, their respective successors and assigns. No other person or entity shall be entitled to claim any right or benefit
hereunder. Nothing herein shall constitute a novation of any Loan Document.

 

		e)	Fees and Expenses. Revenue Sharing Entities shall reimburse Aditxt for all reasonable attorneys' fees and disbursements, receiver's
fees and expenses, expended or incurred by Aditxt in connection with: (a) the enforcement of this Agreement including, without limitation,
during any workout, attempted workout, and/or in connection with the rendering of legal advice as to Aditxts’ rights, remedies and
obligations under this Agreement; (b) any arbitration, mediation, judicial reference proceeding, or other legal action related to this
Agreement, (c) collecting any sum which becomes due to Aditxt under this Agreement; (d) any proceeding for declaratory relief,
any counterclaim to any proceeding, or any appeal; or (e) the protection, preservation or enforcement of any rights of Aditxt. This
includes, subject to any limits under applicable law, Aditxts’ attorneys' fees and legal expenses, whether or not there is a lawsuit,
including attorneys' fees for bankruptcy or other insolvency proceedings (including efforts to modify or vacate any automatic stay or
injunction), appeals, and any anticipated post-judgment collection services.

 

		f)	Further Assurances. Each Revenue Sharing Entity shall execute such additional documents and take such additional actions as
Aditxt may reasonably request to carry out the purpose and intent of this Agreement.

 

		g)	Time is of the Essence. Time is of the essence in the performance of this Agreement.

 

		h)	Credit Agreement Provisions. Article VIII of the Credit Agreement is hereby incorporated herein by this reference mutatis
mutandis. Without limiting the foregoing, each Revenue Sharing Entity agrees, on behalf of itself and its Affiliates, that this Agreement
shall be interpreted in accordance with Delaware law and that any dispute will be determined by and arbitral tribunal in accordance with
Section 8.09(c) of the Credit Agreement.

 

[Signatures on following page]

 

    5

     

    

 

IN WITNESS WHEREOF, the Aditxt and each Revenue Sharing Entity
have executed this Revenue Sharing Agreement as of the date first written above.

 

	ADITXT, INC., a Delaware corporation	 
	 	 
	By: 	/s/ Amro Albanna	 
	Name: 	Amro Albanna	 
	Title: 	CEO	 
	 	 
	CELLVERA GLOBAL HOLDINGS LLC, a Delaware limited liability company f/k/a AIPHARMA GLOBAL HOLDINGS LLC	 
	 	 
	By: 	/s/ Alessandro Gadotti	 
	Name: 	Alessandro Gadotti	 
	Title: 	Legal Representative	 
	 	 
	CELLVERA HOLDINGS LTD, a company formed under the laws of the British Virgin Islands f/k/a AIPHARMA HOLDINGS LIMITED	 
	 	 
	By: 	/s/ Alessandro Gadotti	 
	Name: 	Alessandro Gadotti	 
	Title:	 Legal Representative	 
	 	 
	CELLVERA ASIA LIMITED, a company formed under the laws of Hong Kong f/k/a AIPHARMA ASIA LIMITED	 
	 	 
	By: 	/s/ Alessandro Gadotti	 
	Name: 	Alessandro Gadotti	 
	Title: 	Legal Representative	 
	 	 
	CELLVERA LIMITED, a company formed under the laws of the British Virgin Islands f/k/a AIPHARMA LIMITED	 
	 	 
	By:	 /s/ Alessandro Gadotti	 
	Name:	 Alessandro Gadotti	 
	Title: 	Legal Representative	 

 

 

[Revenue Sharing Agreement – March 2022]

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]